Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6) - Image 1

£111.19

Academic Press Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

Name: Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)
Brand: Academic Press
Price: 111.19 GBP
Availability: InStock

Biological Science

About as cheap as it gets. The only time it was cheaper was 8 months ago.

£111 today · all-time low £111 (Sep 2025) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 640 days • 640 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 640 days • 4 price levels

Days at Price

Current Price

Price Analysis

Most common price: £111 (424 days, 66.3%)

Price range: £111 - £115

Price levels: 4 different prices over 640 days

Description

Improving the Therapeutic Ratio in Head and Neck Cancer provides a complete review of current approaches to modulating therapeutic sensitivity in head and neck cancer. It presents a broad background of current approaches and by highlighting the potential for clinical translational, introduces a roadmap for how to move promising preclinical findings into the clinic. The book discusses topics such as immunotherapy and molecularly targeted therapies in head and neck cancer, PI3k/mTOR pathway, autophagy inhibition to sensitize HNC to radiation and chemotherapy, TAM and Eph/Ephrin family proteins and metabolic reprogramming to modulate therapeutic sensitivity. Additionally, it details approaches to improve the response to immunotherapy, and Chk1/2 inhibition in radiation and cetuximab resistance. This book is a valuable source to head and neck cancer researchers and advanced students, and to those studying specific approaches in other model systems and disease sites. Review Presents novel approaches to improve therapeutic ratio for patients with head and neck cancer About the Author Benjamin Bonavida, PhD, has been involved in the field of immunology and cancer biology for several decades and has published extensively in the fields of cancer resistance, chemotherapy, immunotherapy, and various molecular approaches to circumvent the resistance of the cancer cells using sensitizing agents. Accordingly, he was the first to publish a book on tumor sensitization in 2008. More recently, Dr. Bonavida is the Series Editor of 3 series published by Elsevier/Academic Press (“Cancer Sensitizing Agents for Chemotherapy, “Breaking Cancer Resistance to Therapeutic Antibodies, and “Breaking Tolerance to Anti-Cancer Immunotherapy) and several books have been published and many are in development. He has published extensively in the field of NK biology and cytotoxicity in the past, and many of these publications were in collaboration with the co-editor Dr. Anahid Jewett. Dr. Kimple completed his MD, PhD in Pharmacology, and residency in Radiation Oncology at the University of North Carolina. He is an Associate Professor of Human Oncology at the University of Wisconsin School of Medicine and Public Health where he is a member of the Multidisciplinary Head and Neck Program and the Wisconsin Head and Neck Cancer SPORE Grant. He runs a translational research lab focused on understanding the molecular basis of therapeutic resistance in head and neck cancer.

Product Specifications

Brand: Academic Press
Format: Hardcover
ASIN: 012817868X
Category: Books > Subjects > Science, Nature & Maths > Biological Sciences > Biological Science
Domain: Amazon UK
Release Date: 09 October 2019
Listed Since: 07 June 2019

Barcode

No barcode data available

Academic Press Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

About as cheap as it gets. The only time it was cheaper was 8 months ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Holland-Frei Cancer Medicine - Volume 1 and 2

Cancer Biology and Therapeutics

Cancer Biology and Therapeutics

Targeting Cell Survival Pathways to Enhance Response to Chemotherapy (Volume 3) (Cancer Sensitizing Agents for Chemotherapy, Volume 3)

Targeted Therapies in Oncology

Oxford Textbook of Cancer Biology (Oxford Textbooks in Oncology)

Springer - Signaling Pathways and Molecular Mediators in Metastasis

Handbook of Targeted Cancer Therapy and Immunotherapy

Clinical Evaluation of Antitumor Therapy: 46 (Developments in Oncology, 46)

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Mathematical Oncology 2013 (Modeling and Simulation in Science, Engineering and Technology)

Immunotoxins: 37 (Cancer Treatment and Research, 37)

Immunotoxins: 37 (Cancer Treatment and Research, 37)

Pediatric Oncology: 4 (MD Anderson Cancer Care Series, 4)

Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)

Abeloff's Clinical Oncology

Handbook of Research on Advancements in Cancer Therapeutics (Advances in Medical Diagnosis, Treatment, and Care)

Wiley-Blackwell Cancer Consult: Expertise for Clinical Practice

Manual of Clinical Oncology, Fourth Edition Fully Revised (UICC International Union Against Cancer)

Small Molecules in Oncology: 211 (Recent Results in Cancer Research, 211)

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development)

Elsevier Advances in Oncology, 2022 (Volume 2-1) Medical Book

UICC Manual of Clinical Oncology

Environmental Factors, Genes, and the Development of Human Cancers